J&J unit completes SterilMed buy

Johnson & Johnson's ($JNJ) Ethicon Endo-Surgery unit has closed its acquisition of Maple Grove, MN-based SterilMed, which reprocesses and remanufactures single-use medical devices. SterilMed will still operate as a standalone company focused on growing the market for single-use medical device reprocessing.

"Reprocessing has gained widespread acceptance and we will work to support SterilMed in meeting growing demand from customers," said Karen Licitra, company group chairman and worldwide franchise chairman for EES, in a statement. "Together we will be able to continue meeting clinicians' needs for high-performance medical devices, while also offering quality, cost-effective alternatives for hospitals to consider in order to help save money and reduce waste."

In a separate statement, SterilMed announced it has appointed Mike Gustafson as company president. He succeeds Brian Sullivan, who plans to retire following a transition period.

Gustafson worked most recently as the general manager for the worldwide EES sedation systems business since 2004. He also held positions in sales, marketing, education and business development at J&J's EES and Ethicon units in the U.S. and Asia Pacific regions.

- see the EES release
- get the release on Gustafson

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.